{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:21:41Z","timestamp":1791566501177,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.ccm.2004.10.016","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T13:01:38Z","timestamp":1113397298000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Etiology of Community-Acquired Pneumonia"],"prefix":"10.1016","volume":"26","author":[{"given":"Anucha","family":"Apisarnthanarak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Mundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2004.10.016_bib1","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199512143332408","article-title":"Community-acquired pneumonia","volume":"333","author":"Bartlett","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/srin.2000.18059","article-title":"The epidemiology of respiratory tract infections","volume":"15","author":"File","year":"2000","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.ccm.2004.10.016_bib3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1086\/513953","article-title":"Community-acquired pneumonia in adults: guidelines for management","volume":"26","author":"Bartlett","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0891-5520(05)70199-9","article-title":"The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection","volume":"12","author":"File","year":"1998","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ccm.2004.10.016_bib5","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1164\/ajrccm.152.4.7551387","article-title":"Community-acquired pneumonia: impact of immune status","volume":"152","author":"Mundy","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/313959","article-title":"Canadian guidelines for the initial management of community acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society","volume":"31","author":"Mandell","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/clinids\/11.4.586","article-title":"Community-acquired pneumonia requiring hospitalization: 5-year prospective study","volume":"11","author":"Marrie","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib8","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/infdis\/163.5.1087","article-title":"Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens","volume":"163","author":"Burman","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1164\/ajrccm\/144.2.312","article-title":"Severe community-acquired pneumonia: epidemiology and prognostic factors","volume":"144","author":"Torres","year":"1996","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","article-title":"Prognosis and outcomes of patients with community-acquired pneumonia","volume":"275","author":"Fine","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2004.10.016_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1056\/NEJM199409083311004","article-title":"An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail","volume":"331","author":"Hoge","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM200003093421002","article-title":"Cigarette smoking and invasive pneumococcal disease","volume":"342","author":"Nuorti","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199508243330803","article-title":"The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta","volume":"333","author":"Hofmann","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0272-5231(05)70231-8","article-title":"Drug-resistant pathogens in community- and hospital-acquired pneumonia","volume":"20","author":"Cross","year":"1999","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib15","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1164\/ajrccm.154.5.8912764","article-title":"Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study","volume":"154","author":"Torres","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 4","key":"10.1016\/j.ccm.2004.10.016_bib16","doi-asserted-by":"crossref","first-page":"S273","DOI":"10.1097\/00019048-199811004-00014","article-title":"Comparison of oral cephalosporins and their activities against \u03b2-lactamase producing bacteria","volume":"7","author":"Medeiros","year":"1998","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.ccm.2004.10.016_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0732-8893(97)00195-8","article-title":"Surveillance of antimicrobial resistant in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States in 1996\u20131997 respiratory seasons","volume":"29","author":"Thornsberry","year":"1997","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/thx.53.2.124","article-title":"Lung infections. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen","volume":"53","author":"Murphy","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2004.10.016_bib19","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1128\/jcm.28.12.2674-2680.1990","article-title":"Respiratory tract carrier rate of Moraxella (Branhamella) catarrhalis in adults and children and interpretations of the isolation of M catarrhalis from the sputum","volume":"28","author":"Vaneechoutte","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ccm.2004.10.016_bib20","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/clinids\/9.6.1140","article-title":"Branhamella catarrhalis respiratory infections","volume":"9","author":"Hager","year":"1987","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/jac\/31.6.893","article-title":"In vitro activity of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from US Medical Centers in 1992 and 1993","volume":"37","author":"Barry","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ccm.2004.10.016_bib22","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/313440","article-title":"Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by Methicillin-Resistant and Methicillin-Susceptible organisms","volume":"29","author":"Gonzalez","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib23","series-title":"Respiratory infections: diagnosis and management","first-page":"349","article-title":"Gram-positive pneumonia","author":"Barry","year":"1994"},{"key":"10.1016\/j.ccm.2004.10.016_bib24","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1378\/chest.105.3.826","article-title":"Clinical and epidemiologic investigations of nosocomial pulmonary infections caused by methicillin-resistant Staphylococcus aureus","volume":"105","author":"Iwahara","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2004.10.016_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0272-5231(21)00981-3","article-title":"Pneumonia due to Staphylococcus aureus infection","volume":"16","author":"Al-Ujayli","year":"1995","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib26","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1086\/317486","article-title":"Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: case report and review of the literature","volume":"31","author":"Hatchette","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.ccm.2004.10.016_bib27","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1093\/clinids\/16.Supplement_4.S248","article-title":"Anaerobic bacterial infections of the lung and pleural space","volume":"16","author":"Bartlett","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib28","first-page":"19","article-title":"Anaerobic bacterial pneumonitis","volume":"119","author":"Bartlett","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1128\/jcm.17.2.255-259.1983","article-title":"Diagnosis of bacterial pulmonary infections during quantitative protected catheter cultures obtained during bronchoscopy","volume":"17","author":"Pollock","year":"1983","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ccm.2004.10.016_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/CMR.8.4.451","article-title":"Chlamydia pneumoniae (TWAR)","volume":"8","author":"Kuo","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ccm.2004.10.016_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/clinids\/19.1.157","article-title":"Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay","volume":"19","author":"Gaydos","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM199709043371006","article-title":"Legionellosis","volume":"337","author":"Stout","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib33","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/archinte.1994.00420210049006","article-title":"Surveillance for Legionnaires' disease: risk factors for morbidity and mortality","volume":"154","author":"Martson","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib34","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1001\/archinte.1993.00410220113013","article-title":"Hot tub legionellosis: Legionnaires' disease and Pontiac fever after a point-source exposure to Legionella pneumophila","volume":"153","author":"Thomas","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00002030-199902250-00015","article-title":"The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infections","volume":"13","author":"Paul","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2004.10.016_bib36","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1164\/ajrccm.162.6.9910104","article-title":"Community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients","volume":"162","author":"Cordero","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/clinids\/23.1.107","article-title":"Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies and clinical aspects","volume":"23","author":"Boschini","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199509283331305","article-title":"Bacterial pneumonia in persons infected with the human immunodeficiency virus","volume":"333","author":"Hirschtick","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib39","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1086\/513944","article-title":"Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: a clinical, radiological, microbiological, and epidemiological study","volume":"26","author":"Baril","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib40","first-page":"158","article-title":"Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus","volume":"181","author":"Navin","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib41","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199212243272604","article-title":"A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with human immunodeficiency syndrome","volume":"327","author":"Hardy","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib42","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1378\/chest.113.5.1225","article-title":"Pulmonary complications of HIV infection: autopsy findings","volume":"113","author":"Afessa","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2004.10.016_bib43","first-page":"268","article-title":"The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness","volume":"184","author":"Park","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1007626410724","article-title":"Pseudomonas spp complications in patients with HIV disease: an eight-year clinical and microbiology survey","volume":"16","author":"Manfredi","year":"2000","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ccm.2004.10.016_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-126-2-199701150-00005","article-title":"Incidence of tuberculosis in the United States among HIV-infected persons: the pulmonary complications of HIV Infection Study Group","volume":"126","author":"Markowitz","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00002030-199506000-00008","article-title":"Tuberculosis and HIV infection: a cohort study of incidence and susceptibility to tuberculosis drugs, Bordeaux, 1985\u20131993","volume":"9","author":"Dupon","year":"1995","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2004.10.016_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM199902043400507","article-title":"Tuberculosis in patients with human immunodeficiency virus infection","volume":"340","author":"Havlir","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccm.2004.10.016_bib48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00002030-199704000-00008","article-title":"Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis","volume":"11","author":"Whalen","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2004.10.016_bib49","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1086\/375895","article-title":"Isolated pulmonary Mycobacterium avium complex infection in patients with human immunodeficiency virus infection: case reports and literature review","volume":"37","author":"Salama","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib50","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","volume":"30","author":"Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib51","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1517\/14656566.2.8.1259","article-title":"Treatment of acute cryptococcal disease","volume":"2","author":"Apisarnthanarak","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ccm.2004.10.016_bib52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1086\/318475","article-title":"Dual pulmonary infection with Mycobacterium tuberculosis and Pneumocystis carinii in patients infected with human immunodeficiency virus","volume":"32","author":"Orlovic","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccm.2004.10.016_bib53","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJM198710153171602","article-title":"Trimetrexate in the treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome","volume":"317","author":"Allegra","year":"1987","journal-title":"N Engl J Med"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523104001042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523104001042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:32:49Z","timestamp":1759451569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523104001042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0272523104001042"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2004.10.016","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etiology of Community-Acquired Pneumonia","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2004.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}